Based on the Alaunos Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Alaunos Therapeutics Inc is not available over the next 12 months. Alaunos Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Alaunos Therapeutics Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Alaunos Therapeutics Inc’s stock price was USD 2.84. Alaunos Therapeutics Inc’s stock price has changed by -0.35% over the past week, +14.52% over the past month and -75.52% over the last year.
No recent analyst target price found for Alaunos Therapeutics Inc
No recent average analyst rating found for Alaunos Therapeutics Inc
Company Overview Alaunos Therapeutics Inc
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas. Read Less
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for ...Read More
Frequently Asked Questions About Alaunos Therapeutics Inc (TCRT) Stock
Stock Target Advisor's fundamental analysis for Alaunos Therapeutics Inc's stock is Bearish.
Unfortunately we do not have enough data on TCRT's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TCRT's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on TCRT's stock to indicate if its overvalued.
The last closing price of TCRT's stock was USD 2.84.
The most recent market capitalization for TCRT is USD 4.68M.
Unfortunately we do not have enough analyst data on TCRT's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Alaunos Therapeutics Inc's stock.
As per our most recent records Alaunos Therapeutics Inc has 1 Employees.
Alaunos Therapeutics Inc's registered address is 2617 Bissonnet Street, Houston, TX, United States, 77005.
You can get more information about it from Alaunos Therapeutics Inc's website at https://www.alaunos.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Alaunos Therapeutics Inc (TCRT) Stock
Stock Target Advisor's fundamental analysis for Alaunos Therapeutics Inc's stock is Bearish.
Unfortunately we do not have enough data on TCRT's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TCRT's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on TCRT's stock to indicate if its overvalued.
The last closing price of TCRT's stock was USD 2.84.
The most recent market capitalization for TCRT is USD 4.68M.
Unfortunately we do not have enough analyst data on TCRT's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Alaunos Therapeutics Inc's stock.
As per our most recent records Alaunos Therapeutics Inc has 1 Employees.
Alaunos Therapeutics Inc's registered address is 2617 Bissonnet Street, Houston, TX, United States, 77005.
You can get more information about it from Alaunos Therapeutics Inc's website at https://www.alaunos.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TCRT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
